A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a gain of 42.98%.However, over the last six months, we can see a weaker performance of 78.72%. Over the last 30 days, the price of XERS has fallen by 19.57%. And in the last five days, it has surged by 4.35%.
Xeris Biopharma Holdings Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $3.39 on 11/07/24, and the lowest price during the same period was recorded at $1.46 on 11/15/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of XERS Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Xeris Biopharma Holdings Inc’s current trading price is -0.88% away from its 52-week high, while its distance from the 52-week low is 130.14%. The stock’s price range over this timeframe has been between $1.46 and $3.39. The shares of the Healthcare sector company recorded a trading volume of approximately 2.57 million for the day, which was comparatively higher than the average daily volume of 1.53 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Xeris Biopharma Holdings Inc (XERS) has experienced a quarterly rise of 44.83% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 500.64M and boasts a workforce of 377 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.68, with a change in price of +1.18. Similarly, Xeris Biopharma Holdings Inc recorded 1,432,686 in trading volume during the last 100 days, posting a change of +54.13%.
XERS Stock Stochastic Average
Xeris Biopharma Holdings Inc’s raw stochastic average for the past 50 days is currently at 94.11%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 91.37%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 88.03% and 82.37%, respectively.
